These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 24335386)
1. Left ventricular assist device pump thrombosis: is there a role for glycoprotein IIb/IIIa inhibitors? Bellumkonda L; Subrahmanyan L; Jacoby D; Bonde P ASAIO J; 2014; 60(1):134-6. PubMed ID: 24335386 [TBL] [Abstract][Full Text] [Related]
2. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management. Jennings DL; Weeks PA Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of a continuous flow left ventricular assist device thrombosis with eptifibatide. Jennings DL; Cabrera R; Wang DD; Tita C ASAIO J; 2012; 58(6):633-5. PubMed ID: 23103702 [TBL] [Abstract][Full Text] [Related]
4. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. Thomas MD; Wood C; Lovett M; Dembo L; O'Driscoll G J Heart Lung Transplant; 2008 Aug; 27(8):925-7. PubMed ID: 18656810 [TBL] [Abstract][Full Text] [Related]
6. Medication management for left ventricular assist device thrombosis. Hohner E; Crow J; Moranville MP Am J Health Syst Pharm; 2015 Jul; 72(13):1104-13. PubMed ID: 26092961 [TBL] [Abstract][Full Text] [Related]
7. Pump Thrombosis: A Limitation of Contemporary Left Ventricular Assist Devices. Kapur NK; Vest AR; Cook J; Kiernan MS Curr Probl Cardiol; 2015 Dec; 40(12):511-40. PubMed ID: 26542611 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of Various Treatment Strategies for Patients with Continuous-Flow Ventricular Assist Device Thrombosis: A Retrospective Analysis. Ertugay S; Engin C; Daylan A; Pektok E; Ozturk P; Nalbantgil S; Zoghi M; Yagdi T; Ozbaran M ASAIO J; 2016; 62(5):533-8. PubMed ID: 27258228 [TBL] [Abstract][Full Text] [Related]
9. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy. Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123 [TBL] [Abstract][Full Text] [Related]
11. Increased platelet glycoprotein IIb/IIIa activation precedes continuous-flow left ventricular assist device pump thrombosis events. Weiland M; Schuitema J; Jovinge S; Lee S Thromb Res; 2021 May; 201():143-146. PubMed ID: 33798825 [No Abstract] [Full Text] [Related]
12. The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices. Bitar A; Vijayakrishnan R; Lenneman A; Birks E; Massey T; Slaughter M; Abramov D Artif Organs; 2017 Dec; 41(12):1092-1098. PubMed ID: 28621461 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Left Ventricular Assist Device Thrombosis: Single-Center Experience. Beyazpınar DS; Ersoy Ö; Gültekin B; Aliyev A; Avsever M; Akay HT; Özkan M; Sezgin A; Aşlamacı S Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):165-167. PubMed ID: 29528019 [TBL] [Abstract][Full Text] [Related]
14. Profound thrombocytopenia with glycoprotein IIb/IIIa inhibitors plus heparin for pump thrombus. Blais DM; Sun B; Vesco P; Louis LB; Sai-Sudhakar C; Firstenberg MS J Heart Lung Transplant; 2008 Dec; 27(12):1361-2. PubMed ID: 19059120 [No Abstract] [Full Text] [Related]
15. Platelet inhibition with ticagrelor for left ventricular assist device thrombosis. Oliveira GH; Al-Kindi SG; ElAmm C; Qattan MY; Deo S; Medalion B; Benatti RD; Osman MN; Ginwalla M; Park SJ; Simon DI Circ Heart Fail; 2015 May; 8(3):649-51. PubMed ID: 25991808 [No Abstract] [Full Text] [Related]
16. Tirofiban in Suspected Left Ventricular Assist Device Pump Thrombosis. Nei SD; Wieruszewski PM; Orzel LA; Ritchie BM; Stulak JM ASAIO J; 2020 Aug; 66(8):886-889. PubMed ID: 32740348 [TBL] [Abstract][Full Text] [Related]
17. Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis. Al-Quthami AH; Jumean M; Kociol R; Pham DT; Kiernan M; DeNofrio D; Kapur NK Circ Heart Fail; 2012 Jul; 5(4):e68-70. PubMed ID: 22811551 [No Abstract] [Full Text] [Related]
18. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions. Yoon HC; Miller FJ AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686 [TBL] [Abstract][Full Text] [Related]
20. Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis. Montalto A; Comisso M; Cammardella A; Nicolò F; Gherli R; Palermo A; Pulcinelli F; Musumeci F Transplant Proc; 2019 Nov; 51(9):2986-2990. PubMed ID: 31711580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]